Divalproex Sodium Tablet, Film Coated, Extended Release
Product Images NDC 65862-595

The text shows a graph titled "Reduction In CPS Rate" with two lines displaying the improvement in patients taking Divalproex Sodium Delayed-Release Tablets compared to placebo. The figures are represented as a percentage of patients with improvement, no change or worsening. The graph shows a 50% improvement in patients taking the medication.*

This appears to be a figure (Figure 2) showing the reduction in CPS (Central Nervous System) rate for patients treated with high and low dose Divalproex Sodium delayed-release tablets, where 50% of patients showed improvement, some show no change, and others show worsening. No further information or context is available.*

This text includes numerical values and random letters/words that do not seem to be related or useful for generating a description. The only potentially useful text is the mention of "Divalproex Sodium Extended-Release Tablets" which suggests that this may be related to medication or pharmaceuticals. Therefore, the description would be: "Text appears to be related to numerical values and medication, specifically Divalproex Sodium Extended-Release Tablets."*

This is a description of a medication called Divalproex Sodium Extended-Release Tablets USP used for Valproic Acid Activity. Each tablet contains 250mg of Divalproex Sodium USP equivalent to Valproic Acid. The medication guide must be dispensed to each patient by the pharmacist. The usual dosage can be found in the enclosure for prescribing information. The tablets should be stored at 20° to 25°C and protected from light. They should not be accepted if the seal over the bottle opening is broken or missing. The medication is distributed by Aurobindo Pharma USA, Inc., with a code of TS/DRUGS/22/2009. There is an overprinting zone and coding area, but the dotted lines in the described area are not to be printed.*

This is a description of a medication called Divalproex Sodium, which comes in a coated extended-release tablet and is distributed by Aurchindo Pharma USA, Inc. The tablet contains 500mg of Valproic acid, and is prescribed for once-daily dosing. The usual dosage can be found enclosed with the medication or as a prescribing information. The medication should be stored at controlled room temperature between 20° to 25° ° to 77°F, and protected from light. It comes in a bottle that includes a medication guide that should be given to each patient. The medication should not be used if the seal over the bottle opening is broken or missing.*